Waters Corporation · NYSE:WAT
Waters — J.P. Morgan 40th Annual Healthcare Conference (January 2022)
22 slides from Waters's conference presentation, Jan 10, 2022
Slide 1: J.P. Morgan 40th Annual Healthcare Conference
Udit Batra, Ph.D. President & CEO January 10, 2022 J.P. Morgan 40th Annual Healthcare Conference Exhibit 99.1
Slide 2: Forward-looking statements
This presentation contains forward-looking statements regarding future results and events. For this purpose, any statements that are not statements of historical fact may be deemed forward-looking statements. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” , “projec
Slide 3: Key Messages
Key Messages Resilient and Attractive Base Transformation on Track Focused on Growth
Slide 4: Company Snapshot
Company Snapshot (NYSE:WAT) Note: 1. Based on trailing twelve-months (TTM) as reported, GAAP data for the period ended October 2, 2021; 2. EBITDA Margin = (Earnings before Interest, Taxes, Depreciation, and Amortization) divided by total revenues (of $2.7BN), calculated using as reported, GAAP data
Slide 5: Diversified Portfolio, Customer, and Geographic Base
Diversified Portfolio, Customer, and Geographic Base Note: 1. All data is based on total trailing twelve-month (TTM) as reported, GAAP revenues for the period ended October 2, 2021 (100% = $2.7B); potential for geographic business variation due to Covid-19. Source: Waters Corporation information and
Slide 6: Operate in Markets with Sustainable Growth Drivers
Operate in Markets with Sustainable Growth Drivers Source: Waters data and estimates PHARMA FOOD & ENVIRONMENT MSD Academic & Govt. MSD Manufacturing volume Biologics and novel modalities Outsourcing CLINICAL MATERIALS HSD MSD - HSD Early disease detection Volume of testing Safe food, water, and env
Slide 7: Well-Developed Business Model
Customized Consumables Simplified sophisticated Instruments Informatics designed for regulatory submission 1 2 3 Strong technical expertise Top-ranked Field Services2 150K+ installed base Leader in LC, MS, Thermal Analysis Innovator in small molecule and biologic separations Leader in analytical che
Slide 8: Commitment to Leave the World a Better Place
Commitment to Leave the World a Better Place Note: 1. Against 2016 baseline; GHG = greenhouse gas emissions includes total Scope 1 & 2 (direct); figures as of 2020; 2. Refers to Historically Black Colleges and Universities; 3. By gender and ethnicity Source: Waters data and analysis. Diverse slate a
Slide 9: Key Messages
Key Messages Resilient and Attractive Base Transformation on Track Focused on Growth
Slide 10: Regain Commercial Momentum with Specific Initiatives
Regain Commercial Momentum with Specific Initiatives Regained Momentum and Revitalized Organization Strengthen Performance and Leadership Enhance Portfolio for Growth 1 2 3
Slide 11: Regained Footing Across the Board
Regained Footing Across the Board Note: 2021 EST data are estimates based on year-to-date performance through the end of 3Q21 and internal projections made at that time for the remainder of the year. 2022 and beyond data are estimates based on internal projections made at the end of 3Q21. All data r
Slide 12: Industry-Leading Financial Profile
Industry-Leading Financial Profile Note: 1. Chart based on calculations comparing Waters’ average 2-yr CAGR organic growth rates in constant currency for Q1-Q3 2019 - 21 with that of peers, based on their publicly reported total performance or analytical instrument segment performance (depending on
Slide 13: New Leadership Capabilities in Place
New Leadership Capabilities in Place 2 Udit Batra CEO Jon Pratt Waters Division Jianqing Bennett TA Division Dan Welch Operations Amol Chaubal CFO & IT Dan Rush Strategy & Transformation Kristen Garvey Communications Belinda Hyde HR Keeley Aleman Legal Commercial execution Integration Waters Knowled
Slide 14: Key Messages
Key Messages Resilient and Attractive Base Transformation on Track Focused on Growth
Slide 15: Taking Capabilities into Faster-Growing Adjacencies
Informatics for compliance & quality Customized Consumables Services to maximize productivity and utilization Core Pharma QA/QC Late-Stage Drug Development Food and Environmental Safety Clinical Diagnostics Materials Testing Faster-Growing Adjacencies Bio-separations Bioprocess Characterization LC-M
Slide 16: Core Supported by Instrument Innovation
Core Supported by Instrument Innovation Note: 1. Carryover is sample carryover from a previous experiment / machine run; 2. Compared to competing systems; 3. FWHM = Full Width Half Maximum (FWHM) resolution quality Source: Waters Corporation information and analysis 5x lower carryover1 vs legacy HPL
Slide 17: Custom-Designed Consumables for Novel Modalities
Custom-Designed Consumables for Novel Modalities Note: Chart shows the retention time of the analyte Source: Waters Corporation information and analysis Increased sensitivity for metal-binding analytes like mRNA and complex proteins Better peak shapes and capacity Greater reproducibility for QA/QC F
Slide 18: Solving Critical Problems in High-Growth Adjacencies
Solving Critical Problems in High-Growth Adjacencies Source: IMS/IQVIA Clinical Market Data; M&M Report; Kalorama; BBC Market Report; Waters Corporation information and analysis Bio-separations Separating and purifying newer modalities Bioprocess Characterization Decoupling the process from the prod
Slide 19: Bioprocess Characterization: Clone Cell Selection
Note: 1. PQA = product quality attributes linked to the drug substance Source: Waters Corporation information and analysis BioAccord speeds up time for initial clone cell selection from 6 weeks to 1 week Higher level of process control and better analytics in bioprocessing applications POTENTIAL OPP
Slide 20: Putting It All Together
Putting It All Together Note: Growth rate estimates are for organic growth in constant currency; margin expansion estimates are at constant currency. All data are estimates based on internal projections and represent forward-looking statements and are subject to inherent uncertainties that could cau
Slide 21: Key Messages
Key Messages Resilient and Attractive Base Transformation on Track Focused on Growth
Slide 22: Slide 22
Waters — J.P. Morgan 40th Annual Healthcare Conference (January 2022) on 6ix